Is there ANY role for estramustine phosphate in treatment of CRPC today?

The appropriate, individual treatment of men with metastatic and non-metastatic forms of castration-resistant prostate cancer (CRPC) has become vastly more complicated over the past 5 years. … READ MORE …

The prostate cancer news reports: Wednesday, May 6, 2009

In today’s new items we identified items dealing with:

  • New learnings about radical prostatectomy
  • Heated gold nanoparticles as treatment for solid tumors
  • A three-drug chemotherapy combination for HRPC … READ MORE …

The weekend prostate cancer news: Saturday, January 31, 2009

Items covered in this weekend news report include:

  • Acrylamide exposure as a potential risk for prostate cancer
  • The relative merits of three standard first-line therapies in intermediate risk prostate cancer
  • Estramustine + etopside in hormone-refractory prostate cancer (HRPC)
  • Bone turnover markers and risk for skeletal-related events in patients receiving zoledronic acid … READ MORE …